Microbiota Therapeutics Could Become Strong Ally in IBD Tx
Microbiota therapeutics, such as fecal microbiota transplantation (FMT), could offer more diverse, personalized treatment options for patients with inflammatory bowel disease (IBD), particularly for those with no response or resistance to existing therapies, according to a new review. Treatments that target the microbiome could help when combined with current drugs that alter the immune system,…